Samsung has partnered with medical startup Bottneuro AG. He developed a technology that identifies the region of the brain where Alzheimer’s disease occurs. Then, therapy is performed using our own design Mia Mind neurostimulator. Galaxy Tab S8+ is used to control the neurostimulator and transmit therapy data. This development makes early diagnosis much easier and more economical.
The solution developed during this study will be provided to clinical patients in hospitals in Switzerland. Samsung plans to ship 100 Galaxy Tab S8+ tablets in June.
Source: Ferra
I am a professional journalist and content creator with extensive experience writing for news websites. I currently work as an author at Gadget Onus, where I specialize in covering hot news topics. My written pieces have been published on some of the biggest media outlets around the world, including The Guardian and BBC News.
